NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/17/2024
Back to search
Official data from USPTO
BIOPEPTEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/17/2024
Trademark type
Word
Nice classes
40
Filing date
03/07/2013
Registration date
12/10/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2024
Last transaction
08/17/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/11/2011
First use in commerce
02/11/2011
Drawing code
4
Owner type
16
Owner location
MALVERN, PA, US
Examiner
HAN, DAWN L
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BIOPEPTEK PHARMACEUTICALS LLC
B. I. (pessoa física)
Representatives
BIOPEPTEK PHARMACEUTICALS LLC
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of biopharmaceutical products; Manufacture of biopharmaceutical products to order and/or specification of others; Manufacturing services for others in the field of biopharmaceutical products
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/17/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/15/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/10/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/20/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/20/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2019
E815
TEAS SECTION 8 & 15 RECEIVED
09/19/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2019
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
01/17/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2018
E815
TEAS SECTION 8 & 15 RECEIVED
12/11/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/10/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2013
PUBO
PUBLISHED FOR OPPOSITION
09/24/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/19/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2013
ALIE
ASSIGNED TO LIE
07/08/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/30/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/26/2013
GNRT
NON-FINAL ACTION E-MAILED
06/26/2013
CNRT
NON-FINAL ACTION WRITTEN
06/26/2013
DOCK
ASSIGNED TO EXAMINER
06/18/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/13/2013
NWAP
NEW APPLICATION ENTERED
03/11/2013
Continuous trademark protection
Get notified about every new filing that threatens BIOPEPTEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.